Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit
Globenewswire· 2026-03-26 11:00
Core Insights - Hyperion DeFi, Inc. reported significant growth in its DeFi operating businesses, exceeding Q4 guidance, with a focus on building a premier institutional gateway to DeFi innovation [2][8] - The company achieved a unique "Triple-Dip" HYPE deployment strategy, generating approximately 3x base staking income in Q4 [1][8] - Hyperion DeFi anticipates continued scaling of its business lines through 2026 and beyond, with a projected Adjusted Gross Profit of $4M-$6M for FY'26, approximately 4x the FY'25 results [12][19] Financial Performance - Q4 2025 GAAP revenue reached $496,229, a significant increase from Q3 2025's $302,506 [3] - Adjusted Gross Profit rose by 87% quarter-over-quarter from $439,386 in Q3 2025 to $820,997 in Q4 2025 [3][14] - The company reported a net loss of $39,765,565 in Q4 2025, compared to a net income of $6,625,582 in Q3 2025 [3][19] Token and Asset Management - As of March 23, 2026, the company holds over 1.93 million HYPE tokens, with a gross HYPE holding value of $73.9 million [1][19] - The effective average HYPE price in Q4 2025 was $35.12, down from $45.76 in Q3 2025 [13][19] - Treasury losses amounted to $36,783,228 in Q4 2025, a decline from gains of $11,868,872 in Q3 2025 [3][19] Business Lines and Growth Strategies - The company operates five diversified business lines, including Ecosystem Rewards, DeFi Monetization, Yield Enhancement, Validator Commissions, and Staking Yield [8][12] - Ecosystem Rewards generated $285,000 in Adjusted Gross Profit in Q4 2025, compared to none in Q3 2025 [18] - DeFi Monetization activities saw a significant increase, generating $102,000 in Q4 2025, up from less than $1,000 in Q3 2025 [12][18] Cost Management - Operating expenses excluding stock-based compensation decreased by 30% quarter-over-quarter from $4.3 million in Q3 2025 to $3.0 million in Q4 2025 [19] - Research and development expenses dropped by 49% from $374,000 in Q3 2025 to $189,000 in Q4 2025 [19] Future Outlook - The company has executed a non-binding Letter of Intent (LOI) to monetize the Optejet, with potential closing in Q2 2026 [1][18] - Hyperion DeFi is positioned to benefit from future token airdrops and protocol incentives through its active participation in the Hyperliquid ecosystem [18]
ValOre Reports Positive Leaching Results from Ongoing Metallurgical Program for Pedra Branca PGM Project, Brazil; 73% Platinum and 74% Palladium Achieved Extraction from Weathered Material and 66% Platinum and 79% Palladium from Chromitite;
Globenewswire· 2026-03-26 11:00
Core Viewpoint - ValOre Metals Corp. is advancing its metallurgical test work at the Pedra Branca Platinum Group Elements Project in Brazil, focusing on bioleaching and caustic pre-treatment methods to optimize PGE recovery [1][5]. Metallurgical Test Work - The test work has shown promising results, with bioleaching achieving recoveries of up to 73% platinum and 74% palladium from weathered materials, while caustic pre-treatment on chromitite materials yielded recoveries of up to 66% platinum and 79% palladium [3][9]. - The ongoing metallurgical programs aim to identify optimal processing pathways for PGEs as part of a Preliminary Economic Assessment (PEA) targeted for completion by the end of 2026 [5][6]. Management Commentary - The CEO of ValOre, Nick Smart, emphasized the significance of the test results, highlighting the reproducibility and potential cost and environmental benefits of the bioleaching process [6]. Program Overview - The metallurgical program, conducted by the University of Cape Town, is evaluating bioleaching and caustic cracking as pre-treatment methods to enhance PGE extraction prior to cyanidation [7]. - The tests are designed to validate earlier laboratory findings and advance process selection for materials sourced from the Esbarro deposit [7]. Results Summary - Bioleaching achieved extractions of 72.88% platinum and 74.07% palladium over a 22-day leaching period, consistent with previous results [10]. - Caustic cracking followed by cyanidation achieved extractions of 66.42% platinum and 78.81% palladium, indicating its potential for high-grade chromitite material [11]. Next Steps - ValOre plans to continue advancing the metallurgical evaluation of the bioleaching pathway through additional test phases, including sampling and preparation of fresh and weathered composite samples [12]. - Upcoming tests will include stirred tank reactor testing and heap leach simulation trials to further evaluate both bioleaching and caustic cracking [17]. Resource Information - The Pedra Branca project hosts a 2022 NI 43-101 inferred resource of 2.198 million ounces of 2PGE+Au contained in 63.6 million tonnes, grading 1.08 g/t [20]. - The Esbarro and Curiu deposits have inferred mineral resources of 403,000 ounces at 1.16 g/t and 150,000 ounces at 2.20 g/t, respectively [15].
Labrador Gold Welcomes Recent Announcement by the Ontario Government Concerning Accelerated Development of the Ring of Fire Road
Globenewswire· 2026-03-26 11:00
Core Viewpoint - Labrador Gold Corp. is poised to benefit from the Ontario government's announcement to accelerate the construction of the Ring of Fire road, which will enhance access to the Watson Project and support northern mineral development [1][5]. Group 1: Project Development - The Ontario government plans to begin early works construction of the Ring of Fire road in June 2026, five years ahead of schedule [2]. - The Northern Road Link will intersect the Watson Project, while the Marten Falls Community Access Road will run along the southern side of the northeastern claim block [2]. Group 2: Company Positioning - Labrador Gold, through its joint venture with Nemo Resources Inc., holds the largest landholding in the Fort Hope Greenstone Belt, covering 127,000 hectares [5][11]. - The Watson property is strategically located along three major shear zones that have been largely untested for gold, indicating significant potential for mineralization [6][11]. Group 3: Exploration Plans - The company plans to conduct a 4,582 line-kilometer airborne electromagnetic survey to identify bedrock conductors and magnetic anomalies associated with gold mineralization [8]. - Initial exploration activities, including soil surveying and prospecting, are scheduled for summer 2026, with drilling potentially starting as early as winter 2027 [8]. Group 4: Market Context - Ontario is ranked second globally for investment attractiveness in the Fraser Institute's Annual Survey of Mining Companies (2025), highlighting the favorable environment for mineral exploration [5]. - The Watson Project not only focuses on gold but also has potential for critical minerals such as antimony, nickel, copper, and zinc [11].
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
Globenewswire· 2026-03-26 11:00
Core Insights - Acumen Pharmaceuticals reported significant clinical progress in 2025, particularly in its Phase 2 ALTITUDE-AD study for Alzheimer's disease treatment with its lead candidate, sabirnetug [2][11] - The company anticipates transformative developments in 2026, including topline results from ALTITUDE-AD and advancements in its Enhanced Brain Delivery (EBD) program [2][5] Recent Highlights - Acumen announced a $35.75 million private placement to support its AβO-selective EBD portfolio, following strong preclinical data [6] - The company presented multiple findings at key Alzheimer's conferences, showcasing advancements in its EBD program and the efficacy of sabirnetug [6][12] Anticipated Milestones - Topline results for the ALTITUDE-AD study are expected in late 2026, with an IND filing for the lead clinical candidate in the EBD program targeted for mid-2027 [5][11] - As of December 31, 2025, Acumen had cash and equivalents of $116.9 million, sufficient to support operations into early 2027 [5][11] Financial Results - For the year ended December 31, 2025, Acumen reported R&D expenses of $104.9 million, an increase from $93.8 million in 2024, primarily due to clinical trial costs [11][18] - The net loss for 2025 was $121.3 million, compared to $102.3 million in 2024, reflecting increased operational expenses [11][18]
Cielo Provides Update on Proposed Acquisition and Announces Investor Summit Presentation
Globenewswire· 2026-03-26 11:00
Core Viewpoint - Cielo Waste Solutions Corp. is progressing with its proposed acquisition of proprietary project development and evaluation assets from Canadian Discovery Ltd., with an amendment to the binding letter of intent extending the timeline for completion [1][4][9] Group 1: Proposed Acquisition - The proposed acquisition is subject to finalization of a definitive asset purchase agreement, satisfaction of customary closing conditions, and receipt of necessary corporate and regulatory approvals, including from the TSX Venture Exchange [4] - The original closing date of the acquisition was set before March 31, 2026, but has been extended to April 15, 2026, due to administrative matters [9] - The amendment clarifies that Canadian Discovery Ltd. will remain responsible for seller obligations until a subsidiary is formed to take over these responsibilities [9] Group 2: Webcast Presentation - Cielo's CEO, Ryan C. Jackson, will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026 [2][5] - The webcast will be accessible through the conference home page and will also have a replay available [5] Group 3: Company Overview - Cielo Waste Solutions Corp. focuses on advancing waste-derived feedstocks into sustainable aviation fuel and other low-carbon energy products, leveraging strategic feedstock relationships and proven technologies [6] - The company is developing its initial project in British Columbia while building a scalable pipeline of clean fuels projects across North America and select international markets [6]
Sportradar Expands Partnership with Hard Rock Bet, Adding Official Data from the PGA TOUR and Ultimate Fighting Championship
Globenewswire· 2026-03-26 11:00
Core Insights - Sportradar AG has expanded its multi-year partnership with Hard Rock Bet, introducing new features such as 3D shot tracking and real-time UFC strike analytics for U.S. bettors [3][4][5] Company Developments - The partnership now includes official PGA TOUR and UFC data, enhancing in-play betting capabilities and offering dynamic micro markets like hole winner and hole score [3][4] - Hard Rock Bet will provide users with advanced visualizations, including a real-time leaderboard and automated insights during PGA TOUR events [4] - For UFC events, users will have access to in-play micro markets, including statistics on strikes attempted and landed, as well as a live match tracker [5] Industry Impact - Sportradar aims to enhance the live sports experience for Hard Rock Bet's customers, promoting deeper fan engagement through its comprehensive data and AV portfolio [6][7] - Hard Rock Bet is recognized as the highest-rated real money sports betting app in the U.S., with a rating of 4.9 stars in the App Store, indicating strong user satisfaction [7]
Verde AgriTech Announces Q4 & FY 2025 Earnings Results
Globenewswire· 2026-03-26 11:00
Core Insights - The Great Brazilian Agriculture Crisis has significantly impacted sales, leading to a restrictive credit approval policy by the company to prioritize receivables quality and liquidity preservation [3][11] - Financial results for FY 2025 show a decline in revenue and sales volume, but improvements in gross margin and reduced expected credit losses indicate a focus on disciplined credit-risk management [4][19] Financial Performance - FY 2025 revenue was $16.6 million, down from $21.6 million in FY 2024, with Q4 2025 revenue increasing to $3.1 million from $2.9 million in Q4 2024 [8][19] - Sales volume for FY 2025 totaled 258,432 tons, down from 318,870 tons in FY 2024, with Q4 2025 sales volume at 45,113 tons compared to 47,888 tons in Q4 2024 [8][19] - Gross margin remained stable at 72% for FY 2025, slightly up from 71% in FY 2024, while Q4 2025 gross margin was 63%, down from 65% in Q4 2024 [8][19] - The allowance for expected credit losses decreased to $0.9 million in FY 2025 from $2.3 million in FY 2024, reflecting improved credit management [22][23] Sustainability and Environmental Impact - In Q4 2025, the company's products had the potential to capture up to 5,414 tons of CO₂, with an estimated net carbon removal of 3,940 tons [6] - Since production began in 2018, the cumulative total of potential carbon removal and avoided emissions reached approximately 337,719 tons of CO₂ [6] Market Conditions and Outlook - The Brazilian agricultural input market faced significant financial pressure in 2025, with a 56.4% increase in agribusiness judicial recovery requests, indicating high stress in the sector [11][12] - Despite a projected record grain harvest for 2025/26, credit availability remains a major constraint for growers, impacting fertilizer sales [13][14] - The company anticipates continued challenges in the near term, with Q1 2026 sales volumes expected to remain below the previous year, prompting strategic adjustments to improve cost efficiency [14]
USA Rare Earth Achieves Major Operational and Strategic Milestone with Commissioning of Phase 1a Magnet Production at Stillwater Facility
Globenewswire· 2026-03-26 11:00
Core Insights - USA Rare Earth, Inc. (USAR) has successfully commissioned its commercial magnet production line, allowing it to fulfill customer orders for sintered neodymium-iron-boron (NdFeB) permanent magnets starting in the second quarter of 2026 [1][2] - The company aims to build a globally integrated rare earth value chain, reducing reliance on foreign manufacturing while serving critical industries [2][4] Production Capacity and Process - The commissioning of the production line is a significant milestone in validating the manufacturing process for commercial-grade permanent magnets, which involves multiple complex steps [2] - Phase 1a of the production line is expected to reach a run rate capacity of 600 metric tons per annum (mtpa) by the end of Q4 2026, with total active production capacity anticipated to be 1,200 mtpa by Q1 2027 when combined with Phase 1b [3] Company Overview - USA Rare Earth is establishing a secure and sustainable supply of materials essential for various sectors, including defense, electrification, and advanced manufacturing, by integrating operations across the United States, United Kingdom, and Europe [4]
Abaxx Futures Now Available Through TMX Trayport’s Joule Platform
Globenewswire· 2026-03-26 11:00
Core Viewpoint - Abaxx Technologies has launched its futures trading on TMX Trayport's Joule platform, enhancing trading capabilities for users in the energy and commodities markets [1][2]. Company Overview - Abaxx Technologies Inc. is a financial software and market infrastructure company, primarily focused on developing tools for commodity trading and risk management [1][7]. - The company is the majority shareholder of Abaxx Singapore Pte Ltd., which owns the Abaxx Commodity Exchange and Clearinghouse [1][8]. Product and Service Offering - Abaxx futures are now integrated into TMX Trayport's Joule platform, allowing traders to manage risk more effectively by accessing a broader range of tools [2][3]. - The Joule platform supports over 9,800 traders globally and facilitates cross-market trading and hedging strategies [2][5]. - Abaxx Exchange provides market infrastructure for low-carbon economy transitions through futures contracts in LNG, carbon, battery materials, and precious metals [9][10]. Market Impact - The integration of Abaxx futures into the Joule platform is expected to enhance price discovery and risk management for traders amid current market volatility [3]. - TMX Trayport facilitated over 620 million trades in 2025, indicating a robust trading environment that supports the new offerings from Abaxx [6].
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
Globenewswire· 2026-03-26 11:00
Core Insights - HOOKIPA Pharma Inc. has completed the sale of its immuno-oncology assets, including the HB-200 and HB-700 development programs, to NeoTrail Therapeutics, with the purchase price undisclosed [1] Group 1: HB-200 Overview - HB-200 is an investigational immunotherapeutic agent targeting HPV16 positive cancers, utilizing a combination of attenuated viral vectors HB-201 and HB-202 [2] - Preliminary positive data from a Phase 2 trial of HB-200 in combination with pembrolizumab for recurrent/metastatic HPV16 positive head and neck cancers was presented in November 2024 [2] - HB-200 has received Fast Track Designation from the U.S. FDA and PRIME designation from the European Medicines Agency, developed using HOOKIPA's proprietary arenavirus platform [2] Group 2: HB-700 Overview - HB-700 is an investigational arenaviral immunotherapy aimed at treating KRAS-mutated cancers, including lung, colorectal, and pancreatic cancers [3] - It is a replicating 2-vector therapy targeting prevalent KRAS mutations, potentially benefiting more patients than single mutation inhibitors [3] - HB-700 received Investigational New Drug application clearance from the FDA in April 2024 and is ready for Phase 1 trials, with clinical trial material manufacturing completed [3]